HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients

Clinical Rheumatology

Volumn 34, Issue 4, 2015, Pages 707-714

  Zou, Jing ^a   Guo, Qiang ^a   Chi, Jiachang ^a   Wu, Huawei ^a   Bao, Chunde ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Amyopathic dermatomyositis; Computed tomography; Ferritins; Interstitial; Lung diseases; Mortality

Indexed keywords

ANTIBODY; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FERRITIN; LACTATE DEHYDROGENASE; MDA5 ANTIBODY; METHYLPREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; AMYOPATHIC DERMATOMYOSITIS; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DERMATOMYOSITIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE EXACERBATION; FEMALE; FERRITIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LOG RANK TEST; LUNG FUNCTION; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPHIL LYMPHOCYTE RATIO; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; UNIVARIATE ANALYSIS; BLOOD; CHEMISTRY; CHINA; COMPLICATION; CYTOLOGY; KAPLAN MEIER METHOD; LUNG DISEASE; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME;

CALCINEURIN INHIBITORS; CHINA; DERMATOMYOSITIS; FEMALE; FERRITINS; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHILS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TREATMENT OUTCOME;

EID: 84925484394     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-015-2866-5     Document Type: Article

References (27)

1. Fathi M, Lundberg IE (2005) Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 17:701–706
2. Ye S, Chen XX, Lu XY et al (2007) Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol 26:1647–1654
3. Sato S, Hirakata M, Kuwana M et al (2005) Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52:1571–1576
4. Mukae H, Ishimoto H, Sakamoto N et al (2009) Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 136:1341–1347
5. Fathi M, Lundberg IE, Tornling G (2007) Pulmonary complications of polymyositis and dermatomyositis. Semin Respir Crit Care Med 28:451–458
6. Sontheimer RD (2010) Clinically amyopathic dermatomyositis: what can we now tell our patients? Arch Dermatol 146:76–80
7. Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine’ myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46:626–636
8. Akira M, Hamada H, Sakatani M et al (1997) CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol 168:79–83
9. Bernard GR, Artigas A, Brigham KL et al (1994) The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824
10. Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T et al (2009) RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis Rheum 60:2193–2200
11. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J (2008) Fleischner Society: glossary terms for thoracic imaging. Radiology 246:697–722
12. Ichikado K, Suga M, Müller NL et al (2002) Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and non-survivors. Am J Respir Crit Care Med 165:1551–1556
13. Ichikado K, Suga M, Muranaka H et al (2006) Prediction of prognosis for acute respiratory distress syndrome with thinsection CT: validation in 44 cases. Radiology 238:321–329
14. Akobeng AK (2007) Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 96:644–647
15. Douglas WW, Tazelaar HD, Hartman TE et al (2001) Polymyositis- dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164:1182–1185
16. Marie I, Hachulla E, Cherin P et al (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47:614–622
17. Lakhanpal S, Lie JT, Conn DL, Martin WJ 2nd (1987) Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 46:23–29
18. Lee CS, Chen TL, Tzen CY, Lin FJ, Peng MJ, Wu CL, Chen PJ (2002) Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol 21:391–396
19. Won Huh J, Soon Kim D, Keun Lee C, Yoo B, Bum Seo J, Kitaichi M, Colby TV (2007) Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med 101:1761–1769
20. Suda T, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Naito T, Hashimoto D, Sato J, Toyoshima M, Hashizume H, Chida K (2006) Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J 28:1005–1012
21. Ichikado K, Johkoh T, Ikezoe J et al (1997) Acute interstitial pneumonia: high-resolution CT findings correlated with pathology. AJR Am J Roentgenol 168:333–338
22. Ichikado K, Suga M, Gushima Y et al (2000) Hyperoxiainduced diffuse alveolar damage in pigs: correlation between thin-section CT and histopathologic findings. Radiology 216:531–538
23. Tanizawa K, Handa T, Nakashima R et al (2013) The prognostic value of HRCT in myositis-associated interstitial lung disease. Respir Med 107:745–752
24. Gono T, Kawaguchi Y, Hara M et al (2010) Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology 49:1354–1360
25. Kotani T, Makino S, Takeuchi T et al (2008) Early intervention with corticosteroids and cyclosporin A and 2-h postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis. J Rheumatol 35:254–259
26. Kotani T, Takeuchi T, Makino S et al (2011) Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute/subacute interstitial pneumonia. Clin Rheumatol 30:1021–1028
27. Ando M, Miyazaki E, Yamasue M et al (2010) Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine. Clin Rheumatol 29:443–445